DECODED explores how Foundation Medicine's deep understanding of the genomic changes that contribute to cancer can direct patient-specific treatments. Through expert interviews, we get answers to questions about therapies that may transform patient care.
Foundation Medicine offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.
3. Genomic Testing: Unlocking New HR+ HER2- Breast Cancer Therapies
Today, we are speaking with Dr. Mia Levy, former Chief Medical Officer at Foundation Medicine. With nearly two decades of experience as a medical oncologist specializing in breast cancer, Dr. Levy is a nationally recognized leader in precision oncology and biomedical informatics. Before joining Foundation Medicine, she served as Director of the Cancer Center at Rush University Medical Center and System Vice President for Cancer Services at Rush System for Health. She has extensive expertise in developing data-driven systems to support decision-making in cancer care and research, including leading the development of My Cancer Genome, an international resource for guiding treatment decisions based on tumor genetics.
We discuss some of the latest advancements in breast cancer treatment, including the role of PI3K pathway alterations and acquired alterations in ESR1 in identifying patients who may benefit from targeted therapies. We’ll explore how genomic testing is shaping the future of precision medicine and what these developments mean for both clinicians and patients.
23 Apr 2024
3. Using FoundationOne®Tracker to Bring Clarity to Treatment Response
Today we are speaking with Dr. Jerry Mitchell, a medical oncologist and Director of Field Medical Oncology at Foundation Medicine. Before starting at Foundation Medicine, Dr. Mitchell spent 18 years providing direct patient care in a leading Midwest community practice. Although now at Foundation Medicine, he continues to practice medicine. He has both participated in clinical research and published in leading oncology journals. Today he will be talking to us about FoundationOne®Tracker, a personalized tissue-informed ctDNA monitoring test that provides objective insights to help understand response to treatment for patients with advanced cancer across all solid tumors.
22 Apr 2024
2. Genomic Testing to Identify Targetable Fusions
Today we are speaking with Hanna Tukachinsky and Jessica Lee. Dr. Tukachinsky is a Senior Translational Scientist at Foundation Medicine who focuses on diagnostics and precision oncology. Ms. Lee is a Data Scientist at Foundation Medicine with expertise in genomic data and its clinical applications. They both are co-authors on a recently published paper titled Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
21 Apr 2024
1. ctDNA Tumor Fraction Matters When Interpreting Liquid Biopsy Test Results
Today we are talking with Dr. Lincoln Pasquina, Director of Clinical Development at Foundation Medicine. Dr. Pasquina leads a team that is on the cutting edge of the newest advances in comprehensive genomic profiling. These genomic tests help providers with therapy selection for their patients, expand the number of people who can enroll in trials, increase access to therapies for patients, and accelerate new drug development. Right now, his focus is on liquid biopsy and Foundation Medicine's new ctDNA tumor fraction algorithm that improves confidence in the test, especially when supporting next step decision making concerning negative results.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
66,727
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
3 ratings
Spotify
5.0 / 5
1 ratings
Podcast Authority Score: 28 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
9
Social presence
0
YouTube
85
Engagement
32
Contact DECODED, a podcast from Foundation Medicine
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of DECODED, a podcast from Foundation Medicine?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
